QA: Transcode Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001829635_2022_Transcode_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001829635')"}

Graph

Absolute values for 0001829635, Transcode Therapeutics Inc.

  xvar xval
0 AssetsCurrent 22,732,175
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 206,268
3 remainder_Assets 0
4 LiabilitiesCurrent 2,534,097
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,397,169
9 ResearchAndDevelopmentExpense 2,753,966
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -692,264
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,938,443
1 Liabilities 2,534,097
2 Expenses 6,151,135
3 Revenues 0
4 StockholdersEquity 20,404,346
5 NetIncome -6,843,399
6 ComprehensiveNetIncome -6,843,399
7 BaseVar 16,157,970
8 EconomicCapitalRatio 2.22

Edgar->Model Mapping

Feature Distribution

Change over Time